• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 PPICC SV 3F SL,BASIC, CE; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 PPICC SV 3F SL,BASIC, CE; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS Back to Search Results
Model Number N/A
Device Problem Fluid/Blood Leak (1250)
Patient Problems Bruise/Contusion (1754); Pain (1994)
Event Date 12/20/2022
Event Type  malfunction  
Event Description
It was reported picc power 3 fr.Ultrasound-guided positioning on (b)(6) 2022 in the left brachial/humeral vein.Without technical difficulties reported by the implanter and subsequent execution of ct with contrast medium.On 20/12, [patient] went to the oncology department to start chemotherapy treatment with taxol.At the start of the infusion, the patient feels sharp pain and the procedure is stopped.At the tav clinic, only a small hematoma was found at the catheter insertion point.Ultrasound diagnostics does not show thrombosis or displacement of the catheter present inside the vascular lumen.Ultrasound and physiological contrast medium is injected and the presence of the injected outside the catheter inside the vascular lumen is highlighted.The entire catheter is gently withdrawn under ultrasound guidance.By injecting saline, it breaks in 2-3 points about 10 cm from the cone.Consequence: specific intervention.
 
Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of refr1459 showed no other similar product complaint(s) from this lot number.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, applicable previous investigation(s), sample analysis, complaint and lot history review, applicable manufacture records, and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a leak in the catheter body was confirmed.The product returned for evaluation was 3fr sl powerpicc sv catheter.The investigation findings are consistent with catheter damage caused by contact with a sharp edged instrument such as a scalpel.The returned product sample was evaluated and a split was observed between the 6 and 8cm marks on the catheter tubing.Microscopic examination of the catheter split confirmed it was typical of contact with a sharp bladed instrument, and the characteristics observed which supported this type of failure included: the fracture surface was reflective in nature and contained a striated pattern.This can occur due to pattern transfer of the sharpened edge typically found on a scalpel-type instrument.Sharply formed fracture edges.The short time frame between the insertion date and the date of discovery suggests this damage likely occurred during insertion.An examination of the catheter structure revealed no potential damage/defect related to manufacture of the product.
 
Event Description
It was reported picc power 3 fr.Ultrasound-guided positioning on (b)(6) 2022 in the left brachial/humeral vein.Without technical difficulties reported by the implanter and subsequent execution of ct with contrast medium.On 20/12, [patient] went to the oncology department to start chemotherapy treatment with taxol.At the start of the infusion, the patient feels sharp pain and the procedure is stopped.At the tav clinic, only a small hematoma was found at the catheter insertion point.Ultrasound diagnostics does not show thrombosis or displacement of the catheter present inside the vascular lumen.Ultrasound and physiological contrast medium is injected and the presence of the injected outside the catheter inside the vascular lumen is highlighted.The entire catheter is gently withdrawn under ultrasound guidance.By injecting saline, it breaks in 2-3 points about 10 cm from the cone.Consequence: specific intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PPICC SV 3F SL,BASIC, CE
Type of Device
CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
becky garcia
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key16216929
MDR Text Key308164727
Report Number3006260740-2023-00080
Device Sequence Number1
Product Code LJS
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K102159
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/20/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number66173118
Device Lot NumberREFR1459
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/15/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-